Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Cammarota, G; Ianiro, G; Tilg, H; Rajilić-Stojanović, M; Kump, P; Satokari, R; Sokol, H; Arkkila, P; Pintus, C; Hart, A; Segal, J; Aloi, M; Masucci, L; Molinaro, A; Scaldaferri, F; Gasbarrini, G; Lopez-Sanroman, A; Link, A; de Groot, P; de Vos, WM; Högenauer, C; Malfertheiner, P; Mattila, E; Milosavljević, T; Nieuwdorp, M; Sanguinetti, M; Simren, M; Gasbarrini, A; European FMT Working Group.
European consensus conference on faecal microbiota transplantation in clinical practice.
Gut. 2017; 66(4):569-580
Doi: 10.1136/gutjnl-2016-313017
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Constantini-Kump Patrizia
- Hoegenauer Christoph
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Faecal microbiota transplantation (FMT) is an important therapeutic option for Clostridium difficile infection. Promising findings suggest that FMT may play a role also in the management of other disorders associated with the alteration of gut microbiota. Although the health community is assessing FMT with renewed interest and patients are becoming more aware, there are technical and logistical issues in establishing such a non-standardised treatment into the clinical practice with safety and proper governance. In view of this, an evidence-based recommendation is needed to drive the practical implementation of FMT. In this European Consensus Conference, 28 experts from 10 countries collaborated, in separate working groups and through an evidence-based process, to provide statements on the following key issues: FMT indications; donor selection; preparation of faecal material; clinical management and faecal delivery and basic requirements for implementing an FMT centre. Statements developed by each working group were evaluated and voted by all members, first through an electronic Delphi process, and then in a plenary consensus conference. The recommendations were released according to best available evidence, in order to act as guidance for physicians who plan to implement FMT, aiming at supporting the broad availability of the procedure, discussing other issues relevant to FMT and promoting future clinical research in the area of gut microbiota manipulation. This consensus report strongly recommends the implementation of FMT centres for the treatment of C. difficile infection as well as traces the guidelines of technicality, regulatory, administrative and laboratory requirements. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
- Find related publications in this database (using NLM MeSH Indexing)
- Clostridium difficile -
- Donor Selection -
- Enterocolitis, Pseudomembranous - therapy
- Europe -
- Evidence-Based Medicine -
- Fecal Microbiota Transplantation - adverse effects
- Fecal Microbiota Transplantation - methods
- Fecal Microbiota Transplantation - standards
- Health Facilities -
- Hospital Units - organization & administration
- Humans -
- Patient Selection -
- Specimen Handling - methods